MarketCap
Facebook
X
Telegram
Eyenovia Balance Sheet 2025-2011 | EYEN
Brief overview of Eyenovia's financial position
Balance sheet changes are traced across five available annual reports between 2020 and 2025.
Assets added +52.7%, reaching $51.8 million from $33.9 million five periods earlier; annual growth near 8.8% remained solid.
Liability growth of -42.5% trailed asset growth of +52.7%. The funding structure became more resilient.
Equity accounts for 79.3% of assets. Against the initial 45.1%, the capital position looks resilient.
Negative net debt of -$5.7 million means cash holdings are larger than debt obligations.
Cash accounts for 12.4% of assets versus 83.7% initially. The change indicates the degree of financial flexibility.
Retained earnings remain negative at -$240.6 million. This may reflect past losses or substantial shareholder distributions, so earnings and buybacks provide important context.
Balance sheet takeaway
Eyenovia has a solid balance sheet cushion. Capital and liquidity support development without excessive reliance on debt.
Annual Balance Sheet Eyenovia
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-5.72 M | -829 K | -13.1 M | -21.5 M | - | -27.9 M | -14.1 M | -19.7 M | -5.25 M | -3.39 M | -2.49 M | - | - | - | - |
Long Term Debt |
207 K | 718 K | 1.29 M | 908 K | - | 366 K | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
512 K | 575 K | 501 K | 485 K | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 404 K | 45.4 K | 41.6 K | - | - | - | - | - | - | - |
Total Current Liabilities |
2.7 M | 16 M | 9.53 M | 4.51 M | 11.2 M | 18.2 M | 2.91 M | 3.1 M | 553 K | - | - | - | - | - | - |
Total Liabilities |
10.7 M | 16.8 M | 19.8 M | 13.8 M | 11.2 M | 18.6 M | 2.96 M | 3.14 M | 553 K | 424 K | 420 K | - | - | - | - |
Retained Earnings |
-241 M | -195 M | -145 M | -118 M | -90.2 M | -77.4 M | -57.7 M | -36.5 M | -19.3 M | -14.1 M | -10.6 M | - | - | - | - |
Total Assets |
51.8 M | 3.67 M | 28.8 M | 31 M | 31.7 M | 33.9 M | 14.7 M | 20 M | 5.64 M | 3.43 M | 2.82 M | - | - | - | - |
Cash and Cash Equivalents |
6.44 M | 2.12 M | 14.8 M | 22.9 M | 19.5 M | 28.4 M | 14.2 M | 19.7 M | 5.25 M | 3.39 M | - | - | - | - | - |
Book Value |
41.1 M | -13.1 M | 9 M | 17.2 M | 20.5 M | 15.3 M | 11.7 M | 16.9 M | 5.09 M | 3.01 M | 2.4 M | - | - | - | - |
Total Shareholders Equity |
41.1 M | -13.1 M | 9 M | 17.2 M | 20.5 M | 15.3 M | 11.7 M | 16.9 M | 5.09 M | 3.01 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Eyenovia
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
132 K | 342 K | 473 K | 598 K | 718 K | 836 K | 984 K | 1.14 M | 1.29 M | 1.44 M | 1.58 M | 1.13 M | 908 K | - | - | - | - | - | 7.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
11.6 M | 12 M | 18.3 M | 15.7 M | 16.8 M | 19.1 M | 21.4 M | 24.4 M | 19.8 M | 19.1 M | 18.8 M | 13.5 M | 13.8 M | 11.1 M | 12 M | 10.4 M | 11.2 M | 20.7 M | 21.6 M | 16.7 M | 18.6 M | 18.6 M | 18.6 M | 18.6 M | 2.96 M | 2.96 M | 2.96 M | 2.96 M | 3.14 M | 3.14 M | 3.14 M | 3.14 M | 553 K | 553 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10 M | 10 M | 12 M | 14 M | 14 M | 14 M | 14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-232 M | -201 M | -207 M | -199 M | -195 M | -175 M | -167 M | -156 M | -145 M | -138 M | -130 M | -124 M | -118 M | -112 M | -105 M | -97.6 M | -90.2 M | -93.2 M | -87.6 M | -82.8 M | -77.4 M | -77.4 M | -77.4 M | -77.4 M | -57.7 M | -57.7 M | -57.7 M | -57.7 M | -36.5 M | -36.5 M | -36.5 M | -36.5 M | -19.3 M | -19.3 M | -19.3 M | -19.3 M | -14.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
70.1 M | 82.8 M | 55.7 M | 5.98 M | 3.67 M | 22.8 M | 19 M | 26.2 M | 28.8 M | 34.9 M | 29.3 M | 29.3 M | 31 M | 31.4 M | 35.6 M | 40.2 M | 31.7 M | 25 M | 30.6 M | 28.9 M | 33.9 M | 33.9 M | 33.9 M | 33.9 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 20 M | 20 M | 20 M | 20 M | 5.64 M | 5.64 M | 5.64 M | 5.64 M | 3.43 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
7.38 M | 8.22 M | 7.53 M | 3.93 M | 2.12 M | 7.19 M | 2.3 M | 7.98 M | 14.8 M | 20.7 M | 17.5 M | 18.5 M | 22.9 M | 17.4 M | 21.5 M | 26.7 M | 19.5 M | 13.5 M | 27.2 M | 24.9 M | 28.4 M | 28.4 M | 28.4 M | 28.4 M | 14.2 M | 14.2 M | 14.2 M | 14.2 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 5.25 M | 5.25 M | 5.25 M | 5.25 M | 3.39 M | - | - | - | 2.49 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
58.5 M | 70.8 M | 37.4 M | -9.71 M | -13.1 M | 3.72 M | -2.37 M | 1.82 M | 9 M | 15.8 M | 10.5 M | 15.8 M | 17.2 M | 20.3 M | 23.6 M | 29.8 M | 20.5 M | 4.25 M | 8.99 M | 12.1 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | 5.09 M | 5.09 M | 5.64 M | 5.64 M | 3.43 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
58.5 M | 70.8 M | 37.4 M | -9.71 M | -13.1 M | 3.72 M | -2.37 M | 1.82 M | 9 M | 15.8 M | 10.5 M | 15.8 M | 17.2 M | 20.3 M | 23.6 M | 29.8 M | 20.5 M | 4.25 M | 8.99 M | 12.1 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 16.9 M | 16.9 M | 16.9 M | 16.9 M | 5.09 M | 5.09 M | 5.09 M | 5.09 M | 3.01 M | - | - | - | 2.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Eyenovia, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
Canada
China
Israel
France
Germany
Britain
Russia
Belgium
Cayman-islands
